Abstract

There is increasing interest in the characterization of normative senescence in humans. To assess to what extent aging patterns in humans are unique, comparative data from closely related species, such as non-human primates, can be very useful. Here, we use data from bonobos and chimpanzees, two closely related species that share a common ancestor with humans, to explore physiological markers that are indicative of aging processes. Many studies on aging in humans focus on the somatotropic axis, consisting of growth hormone (GH), insulin-like growth factors (IGFs), and IGF binding proteins (IGFBPs). In humans, IGFBP-3 levels decline steadily with increasing age. We used urinary IGFBP-3 levels as an alternative endocrine marker for IGF-I to identify the temporal pattern known to be related with age-related changes in cell proliferation, growth, and apoptosis. We measured urinary IGFBP-3 levels in samples from 71 bonobos and 102 chimpanzees. Focusing on samples from individuals aged 10 years or older, we found that urinary IGFBP-3 levels decline in both ape species with increasing age. However, in both species, females start with higher urinary IGFBP-3 levels than males, experience a steeper decline with increasing age, and converge with male levels around the age of 30–35 years. Our measurements of urinary IGFBP-3 levels indicate that bonobos and chimpanzees mirror human patterns of age-related decline in IGFBP-3 in older individuals (<10 years) of both sexes. Moreover, such as humans, both ape species show sex-specific differences in IGFBP-3 levels with females having higher levels than males, a result that correlates with sex differences in life expectancy. Using changes in urinary IGFBP-3 levels as a proxy for changes in GH and IGF-I levels that mark age-related changes in cell proliferation, this approach provides an opportunity to investigate trade-offs in life-history strategies in cross-sectional and in longitudinal studies, both in captivity and in the wild.

Highlights

  • Compared to other non-human primates, human life span is longer and longevity increases progressively in all age classes, which translates into an overall “aging” of the human population

  • Given that a decrease with age in serum insulin-like growth factors (IGFs)-I and IGF binding proteins (IGFBPs)-3 levels is consistent with an age-related decline in growth hormone (GH) secretion in humans [43], we assume that the gradual decline in urinary IGFBP-3 levels in the two ape species indicates a corresponding change of GH and IGF-I levels

  • Using a cross-sectional study design, we found that urinary IGFBP-3 levels decline with age in adult individuals of two closely related ape species, bonobos and chimpanzees

Read more

Summary

Introduction

Compared to other non-human primates, human life span is longer and longevity increases progressively in all age classes, which translates into an overall “aging” of the human population. Non-human primates have relatively long life expectancies and in most species, individuals experience a phase of life that is characterized by visible signs of senescence [4]. The time period during which apparently healthy individuals develop alterations in behavior and age-related dysfunctions is longer in non-human primates compared to other animals [2]. These two factors make non-human primates interesting for exploring phenotypic traits of human senescence in an evolutionary context

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.